268 related articles for article (PubMed ID: 15296485)
1. Nicorandil improves diabetes and rat islet beta-cell damage induced by streptozotocin in vivo and in vitro.
Kasono K; Yasu T; Kakehashi A; Kinoshita N; Tamemoto H; Namai K; Ohno R; Ueba H; Kuroki M; Ishikawa S; Kawakami M
Eur J Endocrinol; 2004 Aug; 151(2):277-85. PubMed ID: 15296485
[TBL] [Abstract][Full Text] [Related]
2. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells.
Andersson AK; Sandler S
J Pineal Res; 2001 Apr; 30(3):157-65. PubMed ID: 11316326
[TBL] [Abstract][Full Text] [Related]
3. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role.
Meghana K; Sanjeev G; Ramesh B
Eur J Pharmacol; 2007 Dec; 577(1-3):183-91. PubMed ID: 17900558
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and application of the model of islet impaired by NO free radical released from streptozotocin].
Qian FY; Ouyang F; Fu DX; Ren TR
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):349-52. PubMed ID: 15969020
[TBL] [Abstract][Full Text] [Related]
5. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
Mabley JG; Southan GJ; Salzman AL; Szabó C
Pancreas; 2004 Mar; 28(2):E39-44. PubMed ID: 15028959
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
[TBL] [Abstract][Full Text] [Related]
7. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
Reimers JI; Andersen HU; Mauricio D; Pociot F; Karlsen AE; Petersen JS; Mandrup-Poulsen T; Nerup J
Diabetes; 1996 Jun; 45(6):771-8. PubMed ID: 8635652
[TBL] [Abstract][Full Text] [Related]
8. K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin.
Kullin M; Li Z; Hansen JB; Björk E; Sandler S; Karlsson FA
Diabetes; 2000 Jul; 49(7):1131-6. PubMed ID: 10909969
[TBL] [Abstract][Full Text] [Related]
9. [Improvement of the function of islet beta and alpha cells by intervention against glucotoxicity: experiment with rats].
He QH; Zhou YS; Wang Z; Wang S; Mou ZQ; Li J; Chi JM
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):374-7. PubMed ID: 18581888
[TBL] [Abstract][Full Text] [Related]
10. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.
Katakam AK; Chipitsyna G; Gong Q; Vancha AR; Gabbeta J; Arafat HA
J Endocrinol; 2005 Nov; 187(2):237-47. PubMed ID: 16293771
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxal 5' phosphate protects islets against streptozotocin-induced beta-cell dysfunction--in vitro and in vivo.
Kiran SG; Dorisetty RK; Umrani MR; Boindala S; Bhonde RR; Chalsani M; Singh H; Venkatesan V
Exp Biol Med (Maywood); 2011 Apr; 236(4):456-65. PubMed ID: 21464101
[TBL] [Abstract][Full Text] [Related]
12. Nicorandil attenuates endothelial VCAM-1 expression via thioredoxin production in diabetic rats induced by streptozotocin.
Liu L; Liu Y; Qi B; Wu Q; Li Y; Wang Z
Mol Med Rep; 2014 Jun; 9(6):2227-32. PubMed ID: 24676284
[TBL] [Abstract][Full Text] [Related]
13. Effect of poly(ADP-ribose) synthetase inhibitor administration to streptozotocin-induced diabetic rats on insulin and glucagon contents in their pancreas.
Shima K; Hirota M; Sato M; Numoto S; Oshima I
Diabetes Res Clin Pract; 1987; 3(3):135-42. PubMed ID: 2954803
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
Pospisilik JA; Martin J; Doty T; Ehses JA; Pamir N; Lynn FC; Piteau S; Demuth HU; McIntosh CH; Pederson RA
Diabetes; 2003 Mar; 52(3):741-50. PubMed ID: 12606516
[TBL] [Abstract][Full Text] [Related]
15. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
16. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
Dachicourt N; Serradas P; Bailbé D; Kergoat M; Doaré L; Portha B
J Endocrinol; 1997 Nov; 155(2):369-76. PubMed ID: 9415071
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, as well as inhibiting NF-κB activation and iNOS expression in rat pancreas.
Varsha MK; Thiagarajan R; Manikandan R; Dhanasekaran G
Nutrition; 2015 Jan; 31(1):214-22. PubMed ID: 25466668
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
[TBL] [Abstract][Full Text] [Related]
20.
Boye A; Barku VYA; Acheampong DO; Ofori EG
Biomed Res Int; 2021; 2021():9920826. PubMed ID: 34341763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
